Study of rituximab and mycophenolate mofetil combination therapy compared to placebo for patients with interstitial lung disease related to systemic sclerosis

Registered drug

Study of rituximab and mycophenolate mofetil combination therapy compared to placebo for patients with interstitial lung disease related to systemic sclerosis

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Rituximab
Sponsor:Centre Hospitalier Regional Universitaire De Tours

Contact Research Centre

Muscle spasticity

Recruiting

Study of individualized doses of botulinum toxin type A (incobotulinumtoxin) in adults with severe spasticity caused by brain damage

Registered drugNo placebo

Study of individualized doses of botulinum toxin type A (incobotulinumtoxin) in adults with severe spasticity caused by brain damage

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Botulinum Toxin Type A
Sponsor:Dra. Nuria Gutierrez Dubón

Contact Research Centre

Duchenne muscular dystrophy

Recruiting

Study on the Safety and Effects of Givinostat in Young Children with Duchenne Muscular Dystrophy (Ages 2 to Less Than 6 Years)

InvestigationalNo placebo

Study on the Safety and Effects of Givinostat in Young Children with Duchenne Muscular Dystrophy (Ages 2 to Less Than 6 Years)

InvestigationalNo placebo

Belgium

Participants:0–17 years
Substances:Givinostat
Sponsor:Italfarmaco S.p.A.

Contact Research Centre

Substances studied in this area

The therapies tested most often in Musculoskeletal and connective tissue disorders trials.

Sodium Chloride47 clinical trials Paracetamol32 clinical trials Tocilizumab29 clinical trials Methotrexate26 clinical trials Adalimumab24 clinical trials Rituximab23 clinical trials Cyclophosphamide20 clinical trials Etanercept20 clinical trials Baricitinib17 clinical trials

Musculoskeletal and connective tissue disorders – page 18

Conditions in this area

Clinical trials in Musculoskeletal and connective tissue disorders

872 clinical trials

Systemic lupus erythematosus

Study on the Safety and Effectiveness of CABA-201, Fludarabine Phosphate, and Cyclophosphamide in Patients with Active Systemic Lupus Erythematosus

Systemic lupus erythematosus

Study on Long-Term Safety of Cenerimod for Adults with Moderate-to-Severe Systemic Lupus Erythematosus

Glycogen storage disease type II

Study on the Safety and Effects of SPK-3006 for Adults with Late-Onset Pompe Disease

Rheumatoid arthritis

Study on Adjusting Adalimumab Dosage for Patients with Rheumatoid Arthritis in Remission

Osteoarthritis

Study on the Tolerance of Intra-Articular Injection of Autologous Stromal Vascular Fraction for Adults with Thumb Arthritis (Rhizarthrosis)

Fibrodysplasia ossificans progressiva

Study on the Effectiveness of INCB000928 for Patients with Fibrodysplasia Ossificans Progressiva

Psoriatic arthropathy+1

Study on the Safety and Immune Response of Shingrix Vaccine in Patients with Psoriasis or Psoriatic Arthritis

Osteoarthritis

Study on Treating Knee Osteoarthritis with N-TEC Implant for Patients with Patellofemoral Osteoarthritis

Rheumatoid arthritis+1

Study on Morning vs. Evening Dosing of Tofacitinib for Patients with Rheumatoid or Psoriatic Arthritis

Systemic sclerosis pulmonary

Study of rituximab and mycophenolate mofetil combination therapy compared to placebo for patients with interstitial lung disease related to systemic sclerosis

Muscle spasticity

Study of individualized doses of botulinum toxin type A (incobotulinumtoxin) in adults with severe spasticity caused by brain damage

Duchenne muscular dystrophy

Study on the Safety and Effects of Givinostat in Young Children with Duchenne Muscular Dystrophy (Ages 2 to Less Than 6 Years)

Filter the trials

Substances studied in this area

Prefer not to search? Our Concierge searches the trials for you.